# RE-irradiation of Diffuse MIdline Glioma paTients

> **NCT06093165** · NA · NOT_YET_RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 59 (estimated)

## Conditions studied

- Diffuse Midline Glioma, H3 K27M-Mutant
- Diffuse Intrinsic Pontine Glioma
- Diffuse Glioma
- Pontine Tumors
- Thalamic Tumor
- Brain Tumor, Pediatric

## Interventions

- **RADIATION:** Re-irradiation

## Key facts

- **NCT ID:** NCT06093165
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10
- **Primary completion:** 2029-11
- **Final completion:** 2029-11
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06093165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06093165, "RE-irradiation of Diffuse MIdline Glioma paTients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06093165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*